Simethicone Terminated Phase 4 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02217982Pilot Study to Assess Dimethyl Fumarate Related GI Symptom Mitigation